These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 23408458

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Association study of rs6812193 polymorphism with Parkinson's disease in a Greek population.
    Kalinderi K, Bostantjopoulou S, Katsarou Z, Fidani L.
    Neurosci Lett; 2013 Apr 29; 541():190-2. PubMed ID: 23473716
    [Abstract] [Full Text] [Related]

  • 5. Evidence of an association between the scavenger receptor class B member 2 gene and Parkinson's disease.
    Michelakakis H, Xiromerisiou G, Dardiotis E, Bozi M, Vassilatis D, Kountra PM, Patramani G, Moraitou M, Papadimitriou D, Stamboulis E, Stefanis L, Zintzaras E, Hadjigeorgiou GM.
    Mov Disord; 2012 Mar 29; 27(3):400-5. PubMed ID: 22223122
    [Abstract] [Full Text] [Related]

  • 6. No association of FAM47E rs6812193, SCARB2 rs6825004 and STX1B rs4889603 polymorphisms with Parkinson's disease in a Chinese Han population.
    Chen Y, Yuan X, Cao B, Wei Q, Ou R, Yang J, Chen X, Zhao B, Song W, Wu Y, Shang H.
    J Neural Transm (Vienna); 2015 Nov 29; 122(11):1547-52. PubMed ID: 26224037
    [Abstract] [Full Text] [Related]

  • 7. Association between rs6812193 polymorphism and sporadic Parkinson's disease susceptibility.
    Huo Q, Li T, Zhao P, Wang L.
    Neurol Sci; 2015 Aug 29; 36(8):1479-81. PubMed ID: 25820215
    [Abstract] [Full Text] [Related]

  • 8. Is Parkinson disease associated with lysosomal integral membrane protein type-2?: challenges in interpreting association data.
    Maniwang E, Tayebi N, Sidransky E.
    Mol Genet Metab; 2013 Apr 29; 108(4):269-71. PubMed ID: 23419877
    [Abstract] [Full Text] [Related]

  • 9. SCARB2 variants and glucocerebrosidase activity in Parkinson's disease.
    Alcalay RN, Levy OA, Wolf P, Oliva P, Zhang XK, Waters CH, Fahn S, Kang U, Liong C, Ford B, Mazzoni P, Kuo S, Johnson A, Xiong L, Rouleau GA, Chung W, Marder KS, Gan-Or Z.
    NPJ Parkinsons Dis; 2016 Apr 29; 2():16004-. PubMed ID: 27110593
    [Abstract] [Full Text] [Related]

  • 10. Glucocerebrosidase gene mutations are associated with Parkinson's disease in southern Italy.
    De Marco EV, Annesi G, Tarantino P, Rocca FE, Provenzano G, Civitelli D, Cirò Candiano IC, Annesi F, Carrideo S, Condino F, Nicoletti G, Messina D, Novellino F, Morelli M, Quattrone A.
    Mov Disord; 2008 Feb 15; 23(3):460-3. PubMed ID: 18074383
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Glucocerebrosidase mutations influence the natural history of Parkinson's disease in a community-based incident cohort.
    Winder-Rhodes SE, Evans JR, Ban M, Mason SL, Williams-Gray CH, Foltynie T, Duran R, Mencacci NE, Sawcer SJ, Barker RA.
    Brain; 2013 Feb 15; 136(Pt 2):392-9. PubMed ID: 23413260
    [Abstract] [Full Text] [Related]

  • 14. Relationship between polymorphism of receptor SCARB2 gene and clinical severity of enterovirus-71 associated hand-foot-mouth disease.
    Wang X, Liu H, Li Y, Su R, Liu Y, Qiao K.
    Virol J; 2021 Jun 30; 18(1):132. PubMed ID: 34193186
    [Abstract] [Full Text] [Related]

  • 15. A novel SCARB2 mutation causing late-onset progressive myoclonus epilepsy.
    Higashiyama Y, Doi H, Wakabayashi M, Tsurusaki Y, Miyake N, Saitsu H, Ohba C, Fukai R, Miyatake S, Joki H, Koyano S, Suzuki Y, Tanaka F, Kuroiwa Y, Matsumoto N.
    Mov Disord; 2013 Apr 30; 28(4):552-3. PubMed ID: 23325613
    [No Abstract] [Full Text] [Related]

  • 16. Mutations in the glucocerebrosidase gene are common in patients with Parkinson's disease from Eastern Canada.
    Han F, Grimes DA, Li F, Wang T, Yu Z, Song N, Wu S, Racacho L, Bulman DE.
    Int J Neurosci; 2016 Apr 30; 126(5):415-21. PubMed ID: 26000814
    [Abstract] [Full Text] [Related]

  • 17. Mutations in glucocerebrosidase are a major genetic risk factor for Parkinson's disease and increase susceptibility to dementia in a Flanders-Belgian cohort.
    Crosiers D, Verstraeten A, Wauters E, Engelborghs S, Peeters K, Mattheijssens M, De Deyn PP, Theuns J, Van Broeckhoven C, Cras P.
    Neurosci Lett; 2016 Aug 26; 629():160-164. PubMed ID: 27397011
    [Abstract] [Full Text] [Related]

  • 18. [Advances in research of SCARB2 functions and related disorders].
    He M, Liu Z, Tang B, Wang J.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2015 Oct 26; 32(5):723-7. PubMed ID: 26419000
    [Abstract] [Full Text] [Related]

  • 19. Mutations in the glucocerebrosidase gene and Parkinson disease: phenotype-genotype correlation.
    Aharon-Peretz J, Badarny S, Rosenbaum H, Gershoni-Baruch R.
    Neurology; 2005 Nov 08; 65(9):1460-1. PubMed ID: 16148263
    [Abstract] [Full Text] [Related]

  • 20. Association between Parkinson's disease and glucocerebrosidase mutations in Brazil.
    Spitz M, Rozenberg R, Pereira Lda V, Reis Barbosa E.
    Parkinsonism Relat Disord; 2008 Nov 08; 14(1):58-62. PubMed ID: 17703984
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.